Options thérapeutiques de prise en charge des sarcomes durant la pandémie COVID-19 : propositions du groupe sarcome français
暂无分享，去创建一个
F. Gouin | N. Corradini | N. Penel | S. Bonvalot | S. Carrère | J. Blay | D. Orbach | A. Dufresne | V. Minard | P. Marec-Bérard | C. Llacer | N. Gaspar | S. Briand | A. Le Cesne | M. Brahmi
[1] S. Sleijfer,et al. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018 .
[2] S. Sleijfer,et al. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] S. Sleijfer,et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] J. Blay,et al. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG) , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.